Cholesterol-enriched membrane micro-domaindeficiency induces doxorubicin resistancevia promoting autophagy in breast cancer
Drug resistance has become one of the largest challenges for cancer chemotherapies. Under certain conditions, cancer cells hijack autophagy to cope with therapeutic stress, which largely undermines the chemo-therapeutic efficacy. Currently, biomarkers indicative of autophagy-derived drug resistance...
Guardado en:
Autores principales: | Yin Shi, Zu Ye, Guang Lu, Naidi Yang, Jianbin Zhang, Liming Wang, Jianzhou Cui, Miguel A. del Pozo, Yihua Wu, Dajing Xia, Han-Ming Shen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/784d7619203943aa977f70f75746777f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
por: Singh S
Publicado: (2018) -
Icariin Protects H9c2 Rat Cardiomyoblasts from Doxorubicin-Induced Cardiotoxicity: Role of Caveolin-1 Upregulation and Enhanced Autophagic Response
por: Miriam Scicchitano, et al.
Publicado: (2021) -
Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity
por: Ahmed M. Kabel, et al.
Publicado: (2021) -
Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
por: Jin X, et al.
Publicado: (2016) -
Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer
por: Franco YL, et al.
Publicado: (2018)